{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:06:43Z","timestamp":1786406803584,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd004899.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000}}],"reference-count":86,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004899.pub3","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T05:16:52Z","timestamp":1605849412000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Botulinum toxin type A therapy for hemifacial spasm"],"prefix":"10.1002","volume":"2020","author":[{"given":"Gon\u00e7alo S","family":"Duarte","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Therapeutics; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"},{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe B","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Therapeutics; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"},{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mafalda","family":"Castel\u00e3o","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Therapeutics; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"},{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel E","family":"Marques","sequence":"additional","affiliation":[{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"},{"name":"Ophthalmology University Clinic; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Therapeutics; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"},{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sampaio","sequence":"additional","affiliation":[{"name":"CHDI Foundation; Princeton NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austen P","family":"Moore","sequence":"additional","affiliation":[{"name":"The Walton Centre NHS Foundation Trust; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Costa","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Therapeutics; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"},{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"10.1002\/14651858.CD004899.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000327534","article-title":"Is It always necessary to apply botulinum toxin into the lower facial muscles in hemifacial spasm? A randomized, single-blind, cross-over trial","volume":"65","author":"Colakoglu","year":"2011","journal-title":"European Neurology"},{"issue":"6","key":"10.1002\/14651858.CD004899.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/jnnp.64.6.751","article-title":"Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: report of 175 cases","volume":"64","author":"Jitpimolmard","year":"1998","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0003|cit3","first-page":"427","article-title":"Treatment of hemifacial spasm with type A botulinum toxin (AGN 191622): a dose finding study and the evaluation of clinical effect with electromyography","volume":"51","author":"Mezaki","year":"1999","journal-title":"No To Shinkei - Brain and Nerve"},{"issue":"5","key":"10.1002\/14651858.CD004899.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3346\/jkms.1993.8.5.334","article-title":"Botulinum A toxin treatment of hemifacial spasm and blepharospasm","volume":"8","author":"Park","year":"1993","journal-title":"Journal of Korean Medical Science"},{"issue":"5","key":"10.1002\/14651858.CD004899.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0161-6420(97)30220-6","article-title":"Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections","volume":"104","author":"Price","year":"1997","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD004899.pub3-BIB0006|cit6","first-page":"387","article-title":"Dysbot: a single blind, randomized clinical trial to compare two different formulations of botulinum toxin type A","volume":"10","author":"Sampaio","year":"1995","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1002\/14651858.CD004899.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.870120627","article-title":"DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A - Dysport and Botox - assuming a ratio of 4:1","volume":"12","author":"Sampaio","year":"1997","journal-title":"Movement Disorders"},{"issue":"9","key":"10.1002\/14651858.CD004899.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00415-018-8960-2","article-title":"Botulinum toxin therapy of hemifacial spasm: bilateral injections can reduce facial asymmetry","volume":"265","author":"Xiao","year":"2018","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/mus.880150909","article-title":"Treatment of hemifacial spasm with botulinum toxin","volume":"15","author":"Yoshimura","year":"1992","journal-title":"Muscle & Nerve"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004899.pub3-BIB0010|cit10","first-page":"381(974S)","article-title":"Botulinum toxin therapy for hemifacial spasm","volume":"40","author":"Yoshimura","year":"1990","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD004899.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/ceo.12165","article-title":"Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm","volume":"42","author":"Ababneh","year":"2013","journal-title":"Clinical and Experimental Ophthalmology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1002\/sim.2423","article-title":"Meta-analysis of heterogeneously reported trials assessing change from baseline","volume":"24","author":"Abrams","year":"2005","journal-title":"Statistics in Medicine"},{"issue":"7","key":"10.1002\/14651858.CD004899.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2288-2-3","article-title":"Meta-analysis, Simpson's paradox, and the number needed to treat","volume":"2","author":"Altman","year":"2002","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"3689-96","DOI":"10.1523\/JNEUROSCI.0375-08.2008","article-title":"Long-distance retrograde effects of botulinum neurotoxin","volume":"28","author":"Antonucci","year":"2008","journal-title":"Journal of Neuroscience"},{"issue":"11","key":"10.1002\/14651858.CD004899.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archneur.1990.00530110095023","article-title":"Hemifacial spasm in Rochester and Olmsted County, Minnesota, 1960 to 1984","volume":"47","author":"Auger","year":"1990","journal-title":"Archives of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD004899.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3171\/jns.1995.82.2.0201","article-title":"Microvascular decompression for hemifacial spasm","volume":"82","author":"Barker","year":"1995","journal-title":"Journal of Neurosurgery"},{"issue":"2","key":"10.1002\/14651858.CD004899.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1590\/0004-282x20160191","article-title":"Treatment of hemifacial spasm with botulinum toxin type A: effective, long-lasting and well tolerated","volume":"75","author":"Batisti","year":"2017","journal-title":"Arquivos de Neuropsiquiatria"},{"issue":"8","key":"10.1002\/14651858.CD004899.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/BF00588406","article-title":"Magnetic resonance tomographic angiography in the investigation of hemifacial spasm","volume":"35","author":"Bernardi","year":"1993","journal-title":"Neuroradiology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0021|cit21","first-page":"495-504","article-title":"On the question of permeability of the blood-brain barrier to botulinum toxin","volume":"48","author":"Boroff","year":"1975","journal-title":"International Archives of Allergy and Applied Immunology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1477-7525-4-69","article-title":"How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure","volume":"4","author":"Bro\u017cek","year":"2006","journal-title":"Health and Quality of Life Outcomes"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0023|cit23","first-page":"136","article-title":"Electrophysiologic observations on pathogenic mechanisms of hemifacial spasm: F-waves of the facial muscles and silent period evoked by transcranial magnetic stimulation","volume":"6 Suppl","author":"Cakmur","year":"1999","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0024|cit24","first-page":"129","volume-title":"Handbook of Dystonia","author":"Cardoso","year":"1995"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0025|cit25","doi-asserted-by":"crossref","DOI":"10.1002\/9781119942283","volume-title":"Multiple Imputation and its Application","author":"Carpenter","year":"2013"},{"issue":"2","key":"10.1002\/14651858.CD004899.pub3-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/archopht.1990.01070040101040","article-title":"Familial hemifacial spasm","volume":"108","author":"Carter","year":"1990","journal-title":"Archives of Opthalmology"},{"issue":"12","key":"10.1002\/14651858.CD004899.pub3-BIB0027|cit27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003633.pub3","article-title":"Botulinum toxin type A therapy for cervical dystonia","author":"Castel\u00e3o","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004899.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/eye.2009.192","article-title":"Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes","volume":"24","author":"Cillino","year":"2010","journal-title":"Eye"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0029|cit29","volume-title":"Statistical Power Analysis in the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"1","key":"10.1002\/14651858.CD004899.pub3-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/jrsm.1090","article-title":"Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool","volume":"5","author":"Corbett","year":"2014","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0031|cit31","unstructured":"Deeks JJ Higgins JPT Altman DG Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD004899.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/archneur.59.3.418","article-title":"Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study","volume":"59","author":"Defazio","year":"2002","journal-title":"Archieves of Neurology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0033|cit33","first-page":"3200-5","article-title":"Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals","volume":"96","author":"Paiva","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"10.1002\/14651858.CD004899.pub3-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004314.pub3","article-title":"Botulinum toxin type A versus botulinum toxin type B for cervical dystonia","author":"Duarte","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"16-9","DOI":"10.1016\/j.parkreldis.2018.06.017","article-title":"Adverse events with botulinum toxin treatment in cervical dystonia: How much should we blame placebo","volume":"56","author":"Duarte","year":"2018","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0022-510X(71)90129-8","article-title":"An electron microscopic study of the changes induced by botulinum toxin in the motor end-plates of slow and fast skeletal muscle fibres of the mouse","volume":"14","author":"Duchen","year":"1971","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"400-4","DOI":"10.3109\/00016489309135834","article-title":"Botulinum A toxin effects on rat jaw muscle spindles","volume":"113","author":"Filippi","year":"1993","journal-title":"Acta Oto-laryngologica"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(92)90054-Q","article-title":"Variance imputation for overviews of clinical trials with continuous response","volume":"45","author":"Follmann","year":"1992","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0039|cit39","first-page":"325","article-title":"Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?","volume":"4","author":"Frevert","year":"2010","journal-title":"Biologics: Targets & Therapy"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0040|cit40","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"issue":"12","key":"10.1002\/14651858.CD004899.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0042|cit42","volume-title":"Statistical Methods for Meta-Analysis","author":"Hedges","year":"1985"},{"issue":"7414","key":"10.1002\/14651858.CD004899.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0044|cit44","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0045|cit45","unstructured":"Higgins JPT Deeks JJ Altman DG Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0046|cit46","unstructured":"Higgins JPT and Deeks JJ Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1167-79","DOI":"10.1016\/0306-4522(81)90081-6","article-title":"Nerve growth in botulinum toxin poisoned muscles","volume":"6","author":"Holland","year":"1981","journal-title":"Neuroscience"},{"issue":"5","key":"10.1002\/14651858.CD004899.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/BF00588009","article-title":"Three dimensional MRI of neurovascular compression in patients with hemifacial spasm","volume":"37","author":"Hosoya","year":"1995","journal-title":"Neuroradiology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0049|cit49","first-page":"153","article-title":"Bilateral hemifacial spasm","volume":"10","author":"Jamjoon","year":"1990","journal-title":"Journal of Clinical Neuro-ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD004899.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jnnp.2003.034702","article-title":"Botulinum toxin in clinical practice","volume":"75","author":"Jankovic","year":"2004","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004899.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1017\/cjn.2016.262","article-title":"Real world, long-term quality of life following therapeutic onabotulinumtoxinA treatment","volume":"43","author":"Jog","year":"2016","journal-title":"Canadian Journal of Neurological Sciences [Journal Canadien des Sciences Neurologiques]"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004899.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"I\/21","DOI":"10.1007\/PL00007813","article-title":"Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm","volume":"248","author":"Jost","year":"2001","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD004899.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0960-8966(96)00041-7","article-title":"Nerve terminal sprouting in botulinum type A-treated mouse levator auris longus muscle","volume":"6","author":"Juzans","year":"1996","journal-title":"Neuromuscular Disorders: NMD"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004899.pub3-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1745-6215-15-49","article-title":"Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs)","volume":"15","author":"Macefield","year":"2014","journal-title":"Trials"},{"issue":"5","key":"10.1002\/14651858.CD004899.pub3-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004315.pub3","article-title":"Botulinum toxin type B for cervical dystonia","author":"Marques","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"39-59","DOI":"10.1016\/j.pneurobio.2014.06.001","article-title":"Botulinum toxin A, brain and pain","volume":"119-120","author":"Matak","year":"2014","journal-title":"Progress in Neurobiology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tox.2015.07.003","article-title":"Botulinum neurotoxin type A: actions beyond SNAP-25?","volume":"335","author":"Matak","year":"2015","journal-title":"Toxicology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3171\/jns.1996.84.6.1067","article-title":"Trigeminal neuralgia and hemifacial spasm as false localizing signs in patients with a contralateral mass of the posterior cranial fossa","volume":"84","author":"Matsuura","year":"1996","journal-title":"Journal of Neurosurgery"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0090-3019(92)90170-R","article-title":"Hemifacial spasm due to tumor, aneurysm, or arteriovenous malformation","volume":"38","author":"Nagata","year":"1992","journal-title":"Surgical Neurology"},{"issue":"4","key":"10.1002\/14651858.CD004899.pub3-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/wnl.34.4.427","article-title":"Pathophysiology of hemifacial spasm: II. Lateral spread of the supraorbital nerve reflex","volume":"34","author":"Nielsen","year":"1984","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD004899.pub3-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1212\/wnl.34.7.891","article-title":"Pathophysiology of hemifacial spasm: III. Effects of facial nerve decompression","volume":"34","author":"Nielsen","year":"1984","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004899.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"54-60","DOI":"10.1016\/j.clinph.2011.05.032","article-title":"Neurophysiological changes after intramuscular injection of botulinum toxin","volume":"123","author":"Palomar","year":"2012","journal-title":"Clinical Neurophysiology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0065|cit65","first-page":"259-68","article-title":"Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses","volume":"354","author":"Pellizzari","year":"1999","journal-title":"Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences"},{"issue":"6","key":"10.1002\/14651858.CD004899.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.295.6.676","article-title":"Comparison of two methods to detect publication bias in meta-analysis","volume":"295","author":"Peters","year":"2006","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/14651858.CD004899.pub3-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S1474-4422(18)30310-7","article-title":"Strong nocebo effect in amyotrophic lateral sclerosis trials might mask conclusions","volume":"17","author":"Rato","year":"2018","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.parkreldis.2019.04.015","article-title":"Nocebo response in Parkinson's disease: a systematic review and meta-analysis","volume":"65","author":"Rato","year":"2019","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0069|cit69","unstructured":"Nordic Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"1","key":"10.1002\/14651858.CD004899.pub3-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012405.pub2","article-title":"Deep brain stimulation for dystonia","author":"Rodrigues","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"488-96","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8","article-title":"Extrafusal and intrafusal muscle effects in experimental botulinum toxin A injection","volume":"19","author":"Rosales","year":"1996","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"71-80","DOI":"10.1111\/j.1468-1331.2010.03056.x","article-title":"On muscle spindles, dystonia and botulinum toxin","volume":"17","author":"Rosales","year":"2010","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"585-98","DOI":"10.1002\/sim.4780100410","article-title":"Multiple imputation in health-care databases: an overview and some applications","volume":"10","author":"Rubin","year":"1991","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0074|cit74","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2018Summary of findings' tables. In: Higgins JPT, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook"},{"issue":"12","key":"10.1002\/14651858.CD004899.pub3-BIB0075|cit75","first-page":"1108","article-title":"Hemifacial spasm, quality of life and depression","volume":"29","author":"Serrano-Duenas","year":"1999","journal-title":"Revista de Neurologia"},{"issue":"23","key":"10.1002\/14651858.CD004899.pub3-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1212\/WNL.0000000000004004","article-title":"Placebo and nocebo responses in restless legs syndrome: a systematic review and meta-analysis","volume":"88","author":"Silva","year":"2017","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in botulinum toxin action","volume":"44","author":"Simpson","year":"2004","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"7197","key":"10.1002\/14651858.CD004899.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1136\/bmj.318.7197.1548","article-title":"Numbers needed to treat derived from meta-analysis - sometimes informative, usually misleading","volume":"318","author":"Smeeth","year":"1999","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0161-6420(88)33044-7","article-title":"Hemifacial spasm due to intracranial tumor. An international survey of botulinum toxin investigators","volume":"95","author":"Sprik","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0080|cit80","unstructured":"Stata StataCorp 2017"},{"issue":"10","key":"10.1002\/14651858.CD004899.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1745-6215-8-38","article-title":"OMERACT: an international initiative to improve outcome measurement in rheumatology","volume":"8","author":"Tugwell","year":"2007","journal-title":"Trials"},{"issue":"2","key":"10.1002\/14651858.CD004899.pub3-BIB0083|cit83","first-page":"31","article-title":"Comparison and overview of currently available neurotoxins","volume":"7","author":"Walker","year":"2014","journal-title":"Journal of Clinical and Aesthetic Dermatology"},{"key":"10.1002\/14651858.CD004899.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1740::AID-MUS17>3.0.CO;2-V","article-title":"Hemifacial spasm: clinical findings and treatment","volume":"21","author":"Wang","year":"1998","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.1002\/14651858.CD004899.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jclinepi.2005.08.017","article-title":"A systematic review identifies a lack of standardization in methods for handling missing variance data","volume":"59","author":"Wiebe","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD004899.pub3-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004899.pub2","article-title":"Botulinum toxin type A therapy for hemifacial spasm","author":"Duarte","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T20:05:57Z","timestamp":1623355557000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004899.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Movement Disorders Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":86,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004899.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]}}}